Lifestyle factors related to prevalent chronic disease multimorbidity: A population-based cross-sectional study
PLOS ONE · 24.07.2023 · 18 (7) · e0287263
DOI: 10.1371/journal.pone.0287263 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, online erschienen am 24.07.2023. Verfasst von Jacobien Niebuur und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Life Style. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Ministry of Health, Welfare and Sport, Dutch Ministry of Economic Affairs, University Medical Center Groningen.
Abstract (Originalsprache)
Background
Multimorbidity is associated with poor quality of life, polypharmacy, health care costs and mortality, with those affected potentially benefitting from a healthy lifestyle. We assessed a comprehensive set of lifestyle factors in relation to multimorbidity with major chronic diseases.
Methods
This cross-sectional study utilised baseline data for adults from the prospective Lifelines Cohort in the north of the Netherlands (N = 79,345). We defined multimorbidity as the co-existence of two or more chronic diseases (i.e. cardiovascular disease, cancer, respiratory disease, type 2 diabetes) and evaluated factors in six lifestyle domains (nutrition, physical (in)activity, substance abuse, sleep, stress, relationships) among groups by the number of chronic diseases (≥2, 1, 0). Multinomial logistic regression models were created, adjusted for appropriate confounders, and odds ratios (OR) with 95% confidence intervals (95%CI) were reported.
Results
3,712 participants had multimorbidity (4.7%, age 53.5 ± 12.5 years), and this group tended to have less healthy lifestyles. Compared to those without chronic diseases, those with multimorbidity reported physical inactivity more often (OR, 1.15; 95%CI, 1.06–1.25; not significant for one condition), chronic stress (OR, 2.14; 95%CI, 1.92–2.38) and inadequate sleep (OR, 1.70; 95%CI, 1.41–2.06); as expected, they more often watched television (OR, 1.70; 95%CI, 1.42–2.04) and currently smoked (OR, 1.91; 95%CI, 1.73–2.11), but they also had lower alcohol intakes (OR, 0.66; 95%CI, 0.59–0.74).
Conclusions
Chronic stress and poor sleep, in addition to physical inactivity and smoking, are lifestyle factors of great concern in patients with multimorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
ORCID-Profile: Judith M Vonk, Yihui Du, Geertruida H de Bock, Paul F M Krabbe
Förderung
- Dutch Ministry of Health, Welfare and Sport
- Dutch Ministry of Economic Affairs
- University Medical Center Groningen
- University Groningen
- Northern Provinces of the Netherlands
Zitieren
APA
Niebuur, J., Vonk, J. M., Du, Y., de Bock, G. H., Lunter, G., Krabbe, P. F. M., Alizadeh, B. Z., Snieder, H., Smidt, N., Boezen, M., & Corpeleijn, E. (2023). Lifestyle factors related to prevalent chronic disease multimorbidity: A population-based cross-sectional study. PLOS ONE, 18(7), e0287263. https://doi.org/10.1371/journal.pone.0287263
Vancouver
Niebuur J, Vonk JM, Du Y, de Bock GH, Lunter G, Krabbe PFM, et al. Lifestyle factors related to prevalent chronic disease multimorbidity: A population-based cross-sectional study. PLOS ONE. 2023;18(7):e0287263. doi:10.1371/journal.pone.0287263
BibTeX
@article{Niebuur2023,
author = {Niebuur, Jacobien and Vonk, Judith M and Du, Yihui and de Bock, Geertruida H and Lunter, Gerton and Krabbe, Paul F M and Alizadeh, Behrooz Z and Snieder, Harold and Smidt, Nynke and Boezen, Marike and Corpeleijn, Eva},
title = {Lifestyle factors related to prevalent chronic disease multimorbidity: A population-based cross-sectional study},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {7},
pages = {e0287263},
doi = {10.1371/journal.pone.0287263}
}
EUVIMED